Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
about
The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myelomaImprinted genes and the environment: links to the toxic metals arsenic, cadmium, lead and mercury.Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myelomaArsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway.Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide.Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells.A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
P2860
Q33422349-31EA2186-2F43-4465-88D3-55309D6EE115Q33891724-A3163D8B-53D1-433F-97C0-C3DDB669CC40Q34978872-ECFD83B1-0909-4A0A-B28E-EFA9D790D881Q35260732-D8F3568D-9626-42FF-8AAB-7498D92539E1Q36693641-813E3B64-F3F1-4AD7-8FFD-DDF106FC8912Q39010840-E9A9ED99-619F-4724-A319-0E25759043A1Q39595024-B059A216-DB65-49AE-AE6D-F53C08D69B98Q41029971-C37E8295-5017-46DD-944C-AFD39BC6D280Q41674676-66D65CFD-BE58-4F42-A487-D37848C30DD1Q45342587-0302120C-6B2D-454A-AF43-0BEFF2EB9904Q47630577-D843232A-C52B-460A-A531-FBB7652DCC88
P2860
Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@ast
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@en
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@nl
type
label
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@ast
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@en
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@nl
prefLabel
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@ast
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@en
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@nl
P2093
P2860
P356
P1476
Arsenic trioxide-mediated grow ...... of TRAIL or TRAIL receptor 2.
@en
P2093
Fenghuang Zhan
Guido Tricot
Siyuan Tang
Xiaojing Hu
Xiaosong Wu
Xiuqin Meng
P2860
P304
P356
10.4161/CBT.10.11.13669
P577
2010-12-01T00:00:00Z